NL9001711A - Genetische manipulaties met recombinant dna, dat van rna virus afgeleide sequenties omvat. - Google Patents
Genetische manipulaties met recombinant dna, dat van rna virus afgeleide sequenties omvat. Download PDFInfo
- Publication number
- NL9001711A NL9001711A NL9001711A NL9001711A NL9001711A NL 9001711 A NL9001711 A NL 9001711A NL 9001711 A NL9001711 A NL 9001711A NL 9001711 A NL9001711 A NL 9001711A NL 9001711 A NL9001711 A NL 9001711A
- Authority
- NL
- Netherlands
- Prior art keywords
- rna
- viral
- virus
- derived
- recombinant dna
- Prior art date
Links
- 108020004511 Recombinant DNA Proteins 0.000 title claims abstract description 53
- 241000700605 Viruses Species 0.000 title claims description 49
- 230000002068 genetic effect Effects 0.000 title claims description 15
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims abstract description 141
- 241001493065 dsRNA viruses Species 0.000 claims abstract description 95
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 94
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims abstract description 81
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims abstract description 78
- 230000010076 replication Effects 0.000 claims abstract description 74
- 108020000999 Viral RNA Proteins 0.000 claims abstract description 57
- 239000002773 nucleotide Substances 0.000 claims abstract description 43
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 43
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 38
- 238000000034 method Methods 0.000 claims abstract description 36
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 35
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims abstract description 33
- 210000004027 cell Anatomy 0.000 claims abstract description 30
- 230000001939 inductive effect Effects 0.000 claims abstract description 21
- 108090000565 Capsid Proteins Proteins 0.000 claims abstract description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 18
- 238000010353 genetic engineering Methods 0.000 claims abstract description 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 17
- 230000001419 dependent effect Effects 0.000 claims abstract description 12
- 210000003527 eukaryotic cell Anatomy 0.000 claims abstract description 4
- 210000001236 prokaryotic cell Anatomy 0.000 claims abstract description 4
- 241000196324 Embryophyta Species 0.000 claims description 83
- 101710132601 Capsid protein Proteins 0.000 claims description 59
- 101710094648 Coat protein Proteins 0.000 claims description 59
- 101710125418 Major capsid protein Proteins 0.000 claims description 59
- 101710141454 Nucleoprotein Proteins 0.000 claims description 59
- 101710083689 Probable capsid protein Proteins 0.000 claims description 59
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 48
- 230000003612 virological effect Effects 0.000 claims description 22
- 108020004414 DNA Proteins 0.000 claims description 21
- 108020004999 messenger RNA Proteins 0.000 claims description 19
- 108090000994 Catalytic RNA Proteins 0.000 claims description 18
- 102000053642 Catalytic RNA Human genes 0.000 claims description 18
- 108091092562 ribozyme Proteins 0.000 claims description 18
- 230000000692 anti-sense effect Effects 0.000 claims description 15
- 238000013519 translation Methods 0.000 claims description 15
- 238000013518 transcription Methods 0.000 claims description 12
- 230000035897 transcription Effects 0.000 claims description 12
- 238000005520 cutting process Methods 0.000 claims description 9
- 108020005544 Antisense RNA Proteins 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000006467 substitution reaction Methods 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 241000726448 Satellite tobacco mosaic virus Species 0.000 description 150
- 239000013612 plasmid Substances 0.000 description 81
- 208000015181 infectious disease Diseases 0.000 description 69
- 241000709655 unidentified tobacco necrosis virus Species 0.000 description 66
- 239000012634 fragment Substances 0.000 description 40
- 238000012217 deletion Methods 0.000 description 29
- 230000037430 deletion Effects 0.000 description 29
- 235000018102 proteins Nutrition 0.000 description 29
- 108010060309 Glucuronidase Proteins 0.000 description 22
- 102000053187 Glucuronidase Human genes 0.000 description 20
- 241000588724 Escherichia coli Species 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 19
- 238000003780 insertion Methods 0.000 description 19
- 230000037431 insertion Effects 0.000 description 19
- 241000219977 Vigna Species 0.000 description 18
- 235000010726 Vigna sinensis Nutrition 0.000 description 18
- 244000061176 Nicotiana tabacum Species 0.000 description 16
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 16
- 101150054900 gus gene Proteins 0.000 description 15
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 15
- 230000009466 transformation Effects 0.000 description 14
- 239000002054 inoculum Substances 0.000 description 13
- 150000001413 amino acids Chemical class 0.000 description 12
- 108020004705 Codon Proteins 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000009396 hybridization Methods 0.000 description 11
- 229930027917 kanamycin Natural products 0.000 description 11
- 229960000318 kanamycin Drugs 0.000 description 11
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 11
- 229930182823 kanamycin A Natural products 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 230000014616 translation Effects 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 10
- 238000010367 cloning Methods 0.000 description 10
- 230000003902 lesion Effects 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- 238000010276 construction Methods 0.000 description 9
- 238000012546 transfer Methods 0.000 description 9
- 238000001262 western blot Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- GGKNTGJPGZQNID-UHFFFAOYSA-N (1-$l^{1}-oxidanyl-2,2,6,6-tetramethylpiperidin-4-yl)-trimethylazanium Chemical compound CC1(C)CC([N+](C)(C)C)CC(C)(C)N1[O] GGKNTGJPGZQNID-UHFFFAOYSA-N 0.000 description 6
- 102100039601 ARF GTPase-activating protein GIT1 Human genes 0.000 description 6
- 101710194905 ARF GTPase-activating protein GIT1 Proteins 0.000 description 6
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 6
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical compound [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 6
- 101710081758 High affinity cationic amino acid transporter 1 Proteins 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 230000032258 transport Effects 0.000 description 6
- 230000009385 viral infection Effects 0.000 description 6
- 101800004538 Bradykinin Proteins 0.000 description 5
- 101100465058 Caenorhabditis elegans prk-2 gene Proteins 0.000 description 5
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 241001515849 Satellite Viruses Species 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000006870 ms-medium Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 4
- 101100468275 Caenorhabditis elegans rep-1 gene Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 4
- 101100215778 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ptr-1 gene Proteins 0.000 description 4
- 238000000636 Northern blotting Methods 0.000 description 4
- 241000219833 Phaseolus Species 0.000 description 4
- 108091081024 Start codon Proteins 0.000 description 4
- 108091027544 Subgenomic mRNA Proteins 0.000 description 4
- 208000036142 Viral infection Diseases 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 4
- 229960005091 chloramphenicol Drugs 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 108020001507 fusion proteins Proteins 0.000 description 4
- 102000037865 fusion proteins Human genes 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 102400000967 Bradykinin Human genes 0.000 description 3
- 101100326684 Caenorhabditis elegans tra-3 gene Proteins 0.000 description 3
- 108010078791 Carrier Proteins Proteins 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 3
- 102000004594 DNA Polymerase I Human genes 0.000 description 3
- 108010017826 DNA Polymerase I Proteins 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 101150087882 GUS1 gene Proteins 0.000 description 3
- 229930182566 Gentamicin Natural products 0.000 description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
- 102100034349 Integrase Human genes 0.000 description 3
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 244000042314 Vigna unguiculata Species 0.000 description 3
- 235000010722 Vigna unguiculata Nutrition 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 229940088530 claforan Drugs 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000000644 propagated effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 101150058668 tra2 gene Proteins 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 2
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229930192334 Auxin Natural products 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000714206 Carnation mottle virus Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 101100445488 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ptr-2 gene Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
- 108020005543 Satellite RNA Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 241000272534 Struthio camelus Species 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 241000714211 Turnip crinkle virus Species 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 108010068991 arginyl-threonyl-prolyl-prolyl-prolyl-seryl-glycine Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000002363 auxin Substances 0.000 description 2
- 101150055766 cat gene Proteins 0.000 description 2
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 2
- 239000004062 cytokinin Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FLUSEOZMBNGLSB-HNTFPEDGSA-N (2S,3R,4R,5R,6R)-2-bromo-3-chloro-3,4,5,6-tetrahydroxy-4-(1H-indol-2-yl)oxane-2-carboxylic acid Chemical compound O[C@H]1[C@H](O)O[C@](Br)(C(O)=O)[C@](O)(Cl)[C@@]1(O)C1=CC2=CC=CC=C2N1 FLUSEOZMBNGLSB-HNTFPEDGSA-N 0.000 description 1
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 1
- RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 1
- 102100039602 ARF GTPase-activating protein GIT2 Human genes 0.000 description 1
- 241000724328 Alfalfa mosaic virus Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000712892 Arenaviridae Species 0.000 description 1
- 241000724306 Barley stripe mosaic virus Species 0.000 description 1
- 241000709756 Barley yellow dwarf virus Species 0.000 description 1
- 241000710149 Beet yellows virus Species 0.000 description 1
- 241000702628 Birnaviridae Species 0.000 description 1
- 241001086826 Branta bernicla Species 0.000 description 1
- 241000724256 Brome mosaic virus Species 0.000 description 1
- 241000714198 Caliciviridae Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000710173 Carnation latent virus Species 0.000 description 1
- 241000723666 Carnation ringspot virus Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108091028075 Circular RNA Proteins 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000723655 Cowpea mosaic virus Species 0.000 description 1
- 241000724252 Cucumber mosaic virus Species 0.000 description 1
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 101710091045 Envelope protein Proteins 0.000 description 1
- 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 1
- 241001288713 Escherichia coli MC1061 Species 0.000 description 1
- 241000710781 Flaviviridae Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 101710132031 Mantle protein Proteins 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- OTCCIMWXFLJLIA-BYPYZUCNSA-N N-acetyl-L-aspartic acid Chemical compound CC(=O)N[C@H](C(O)=O)CC(O)=O OTCCIMWXFLJLIA-BYPYZUCNSA-N 0.000 description 1
- 241000723741 Nodaviridae Species 0.000 description 1
- 108091060545 Nonsense suppressor Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 241000712464 Orthomyxoviridae Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000711504 Paramyxoviridae Species 0.000 description 1
- 101710091688 Patatin Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241001443531 Pea enation mosaic virus 1 Species 0.000 description 1
- 241000150350 Peribunyaviridae Species 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 241000709992 Potato virus X Species 0.000 description 1
- 101710188315 Protein X Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 102000017143 RNA Polymerase I Human genes 0.000 description 1
- 108010013845 RNA Polymerase I Proteins 0.000 description 1
- 208000009341 RNA Virus Infections Diseases 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 241001084365 RNA satellites Species 0.000 description 1
- 241000702247 Reoviridae Species 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 241000712907 Retroviridae Species 0.000 description 1
- 241000711931 Rhabdoviridae Species 0.000 description 1
- 108091006231 SLC7A2 Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000710117 Southern bean mosaic virus Species 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 241000723573 Tobacco rattle virus Species 0.000 description 1
- 241000724291 Tobacco streak virus Species 0.000 description 1
- 241000710924 Togaviridae Species 0.000 description 1
- 241000723694 Tomato black ring virus Species 0.000 description 1
- 241000710145 Tomato bushy stunt virus Species 0.000 description 1
- 241000016010 Tomato spotted wilt orthotospovirus Species 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 241000710155 Turnip yellow mosaic virus Species 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- 239000000061 acid fraction Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004656 cell transport Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- -1 chloramphenicol acetvl Chemical class 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- KRZWEBVPFGCYMY-UHFFFAOYSA-M methylmercury(1+);hydroxide Chemical compound [OH-].[Hg+]C KRZWEBVPFGCYMY-UHFFFAOYSA-M 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 208000013435 necrotic lesion Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229930010796 primary metabolite Natural products 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/38011—Tombusviridae
- C12N2770/38022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL9001711A NL9001711A (nl) | 1989-10-03 | 1990-07-27 | Genetische manipulaties met recombinant dna, dat van rna virus afgeleide sequenties omvat. |
| CA002026703A CA2026703C (en) | 1989-10-03 | 1990-10-02 | Genetic manipulations with recombinant dna comprising sequences derived from rna virus |
| CA002396794A CA2396794A1 (en) | 1989-10-03 | 1990-10-02 | Genetic manipulations with recombinant dna comprising sequences derived from rna virus |
| EP90202627A EP0425004B1 (en) | 1989-10-03 | 1990-10-03 | Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus |
| IE354190A IE76133B1 (en) | 1989-10-03 | 1990-10-03 | Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus |
| JP2266173A JPH03280883A (ja) | 1989-10-03 | 1990-10-03 | Ｒｎａ型ウイルス由来の配列を包含する組換えｄｎａおよびそれを用いる遺伝子操作方法 |
| DK90202627.7T DK0425004T3 (https=) | 1989-10-03 | 1990-10-03 | |
| DE69028479T DE69028479T2 (de) | 1989-10-03 | 1990-10-03 | Genetische Manipulationen mit von RNA-Viren abgeleiteten Sequenzen enthaltendem rekombinantem DNA |
| PT95494A PT95494B (pt) | 1989-10-03 | 1990-10-03 | Processo para a producao de dna recombinante compreendendo sequencias derivadas de virus de rna, e manipulacoes geneticas que o utilizam |
| ES90202627T ES2094744T3 (es) | 1989-10-03 | 1990-10-03 | Manipulaciones geneticas con el adn recombinante que contiene secuencias derivadas de los virus arn. |
| AT90202627T ATE142700T1 (de) | 1989-10-03 | 1990-10-03 | Genetische manipulationen mit von rna-viren abgeleiteten sequenzen enthaltendem rekombinantem dna |
| GR960403367T GR3021950T3 (en) | 1989-10-03 | 1996-12-10 | Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus |
| US08/901,379 US6197542B1 (en) | 1989-10-03 | 1997-07-28 | Genetic manipulations with recombinant DNA comprising sequences derived from RNA virus |
| US09/234,163 US6093554A (en) | 1989-10-03 | 1999-01-21 | Genetics manipulations with recombinant DNA virus comprising sequences derived from RNA virus |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8902452 | 1989-10-03 | ||
| NL8902452A NL8902452A (nl) | 1989-10-03 | 1989-10-03 | Genetische manipulaties met recombinant dna, dat rna-virus-specifieke sequenties omvat. |
| NL9001711 | 1990-07-27 | ||
| NL9001711A NL9001711A (nl) | 1989-10-03 | 1990-07-27 | Genetische manipulaties met recombinant dna, dat van rna virus afgeleide sequenties omvat. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL9001711A true NL9001711A (nl) | 1991-05-01 |
Family
ID=26646589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL9001711A NL9001711A (nl) | 1989-10-03 | 1990-07-27 | Genetische manipulaties met recombinant dna, dat van rna virus afgeleide sequenties omvat. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6197542B1 (https=) |
| EP (1) | EP0425004B1 (https=) |
| JP (1) | JPH03280883A (https=) |
| AT (1) | ATE142700T1 (https=) |
| CA (2) | CA2396794A1 (https=) |
| DE (1) | DE69028479T2 (https=) |
| DK (1) | DK0425004T3 (https=) |
| ES (1) | ES2094744T3 (https=) |
| GR (1) | GR3021950T3 (https=) |
| IE (1) | IE76133B1 (https=) |
| NL (1) | NL9001711A (https=) |
| PT (1) | PT95494B (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7033835B1 (en) | 1988-02-26 | 2006-04-25 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
| US5922602A (en) * | 1988-02-26 | 1999-07-13 | Biosource Technologies, Inc. | Cytoplasmic inhibition of gene expression |
| US5977438A (en) * | 1988-02-26 | 1999-11-02 | Biosource Technologies, Inc. | Production of peptides in plants as viral coat protein fusions |
| US6660500B2 (en) | 1988-02-26 | 2003-12-09 | Large Scale Biology Corporation | Production of peptides in plants as viral coat protein fusions |
| US6054566A (en) | 1988-02-26 | 2000-04-25 | Biosource Technologies, Inc. | Recombinant animal viral nucleic acids |
| JPH07503361A (ja) * | 1991-08-01 | 1995-04-13 | バイオソース テクノロジーズ インコーポレイティド | 組み換え植物ウィルス核酸 |
| ATE276373T1 (de) * | 1991-10-04 | 2004-10-15 | Univ North Carolina State | Pathogenresistente transgene pflanzen |
| CA2130454C (en) * | 1992-02-19 | 2008-04-08 | William G. Dougherty | Production of viral resistant plants via introduction of untranslatable plus sense viral rna |
| EP0641384A4 (en) * | 1992-05-14 | 1995-07-12 | Ribozyme Pharm Inc | INDUCIBLE CYTOTOXIC mRNAs CONTAINING VIRUS-RESISTANT PLANTS. |
| EP0677113B1 (en) * | 1992-12-30 | 2003-03-12 | Biosource Genetics Corporation | Viral amplification of recombinant messenger rna in transgenic plants |
| IL108241A (en) * | 1992-12-30 | 2000-08-13 | Biosource Genetics Corp | Plant expression system comprising a defective tobamovirus replicon integrated into the plant chromosome and a helper virus |
| US6008436A (en) * | 1993-01-21 | 1999-12-28 | North Carolina State University | Nematode-resistant transgenic plants |
| US5650303A (en) * | 1993-02-26 | 1997-07-22 | Calgene, Inc. | Geminivirus-based gene expression system |
| DK0686197T3 (da) * | 1993-02-26 | 2000-09-04 | Calgene Llc | Geminivirusbaseret genekspressionssystem |
| US5981236A (en) * | 1993-02-26 | 1999-11-09 | Calgene Inc | Geminivirus-based gene expression system |
| DE4315109A1 (de) * | 1993-05-06 | 1994-11-10 | Inst Pflanzengenetik & Kultur | Verfahren und Vektorkonstrukt zur Expressionssteigerung von Transgenen |
| GB9311593D0 (en) * | 1993-06-04 | 1993-07-21 | Sandoz Ltd | Improvements in or relating to organic compounds |
| GB9401780D0 (en) * | 1994-01-31 | 1994-03-23 | Nickerson Biocem Ltd | Modified plants |
| AU3409295A (en) * | 1994-08-18 | 1996-03-14 | Ariad Gene Therapeutics, Inc. | Regulatable elimination of gene expression, gene product function and engineered host cells |
| IT1283631B1 (it) * | 1996-05-09 | 1998-04-23 | Metapontum Agrobios Srl | Metodo per la preparazione di piante transgeniche resistenti ad in- fezioni virali e piante cosi' ottenute |
| GB9615349D0 (en) * | 1996-07-22 | 1996-09-04 | Zeneca Ltd | Virus resistance in plants |
| GB9703146D0 (en) * | 1997-02-14 | 1997-04-02 | Innes John Centre Innov Ltd | Methods and means for gene silencing in transgenic plants |
| GB9720148D0 (en) * | 1997-09-22 | 1997-11-26 | Innes John Centre Innov Ltd | Gene silencing materials and methods |
| AU731330B2 (en) * | 1997-10-24 | 2001-03-29 | E.I. Du Pont De Nemours And Company | Binary viral expression system in plants |
| US6077992A (en) * | 1997-10-24 | 2000-06-20 | E. I. Du Pont De Nemours And Company | Binary viral expression system in plants |
| US6632980B1 (en) | 1997-10-24 | 2003-10-14 | E. I. Du Pont De Nemours And Company | Binary viral expression system in plants |
| US6759243B2 (en) | 1998-01-20 | 2004-07-06 | Board Of Trustees Of The University Of Illinois | High affinity TCR proteins and methods |
| HUP0104697A3 (en) * | 1998-09-23 | 2003-12-29 | Du Pont | Binary viral expression system in plants |
| US7220893B1 (en) | 1999-05-19 | 2007-05-22 | Cornell Research Foundation, Inc. | Plasmids and methods for construction of non-redundant, indexed, saturation, gene-disruption plant and animal libraries |
| US7696406B2 (en) * | 2003-07-03 | 2010-04-13 | Board Of Trustees Operating Michigan State University | Expression of a recombinant transgene |
| CN110144338A (zh) * | 2019-05-29 | 2019-08-20 | 通用生物系统（安徽）有限公司 | 一种以rna为模板的rna聚合酶制备方法及该聚合酶的应用 |
| US12234701B2 (en) | 2022-09-12 | 2025-02-25 | Saudi Arabian Oil Company | Tubing hangers and related methods of isolating a tubing |
| US12188328B2 (en) | 2023-05-15 | 2025-01-07 | Saudi Arabian Oil Company | Wellbore back pressure valve with pressure gauge |
| US12442257B2 (en) | 2023-05-23 | 2025-10-14 | Saudi Arabian Oil Company | Completing and working over a wellbore |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2624342B1 (fr) * | 1987-12-14 | 1991-11-08 | Agronomique Inst Nat Rech | Procede d'obtention de plantes transgeniques, vecteur d'integration utilise et plantes obtenues |
| AU638411B2 (en) * | 1988-02-26 | 1993-07-01 | Large Scale Biology Corporation | Non-nuclear chromosomal transformation |
| CN1033645A (zh) * | 1988-10-22 | 1989-07-05 | 中国科学院上海植物生理研究所 | 控制植物病毒病的基因工程方法 |
-
1990
- 1990-07-27 NL NL9001711A patent/NL9001711A/nl not_active Application Discontinuation
- 1990-10-02 CA CA002396794A patent/CA2396794A1/en not_active Abandoned
- 1990-10-02 CA CA002026703A patent/CA2026703C/en not_active Expired - Fee Related
- 1990-10-03 PT PT95494A patent/PT95494B/pt active IP Right Grant
- 1990-10-03 AT AT90202627T patent/ATE142700T1/de not_active IP Right Cessation
- 1990-10-03 DE DE69028479T patent/DE69028479T2/de not_active Expired - Fee Related
- 1990-10-03 EP EP90202627A patent/EP0425004B1/en not_active Expired - Lifetime
- 1990-10-03 DK DK90202627.7T patent/DK0425004T3/da active
- 1990-10-03 JP JP2266173A patent/JPH03280883A/ja active Pending
- 1990-10-03 ES ES90202627T patent/ES2094744T3/es not_active Expired - Lifetime
- 1990-10-03 IE IE354190A patent/IE76133B1/en not_active IP Right Cessation
-
1996
- 1996-12-10 GR GR960403367T patent/GR3021950T3/el unknown
-
1997
- 1997-07-28 US US08/901,379 patent/US6197542B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE142700T1 (de) | 1996-09-15 |
| JPH03280883A (ja) | 1991-12-11 |
| DK0425004T3 (https=) | 1997-03-10 |
| EP0425004B1 (en) | 1996-09-11 |
| ES2094744T3 (es) | 1997-02-01 |
| GR3021950T3 (en) | 1997-03-31 |
| IE76133B1 (en) | 1997-10-08 |
| US6197542B1 (en) | 2001-03-06 |
| CA2396794A1 (en) | 1991-04-04 |
| DE69028479D1 (de) | 1996-10-17 |
| CA2026703C (en) | 2002-11-26 |
| DE69028479T2 (de) | 1997-04-03 |
| IE903541A1 (en) | 1991-04-10 |
| PT95494B (pt) | 1997-11-28 |
| PT95494A (pt) | 1991-09-13 |
| EP0425004A3 (en) | 1991-08-07 |
| EP0425004A2 (en) | 1991-05-02 |
| CA2026703A1 (en) | 1991-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL9001711A (nl) | Genetische manipulaties met recombinant dna, dat van rna virus afgeleide sequenties omvat. | |
| DE68929521T2 (de) | Nicht-nukleare chromosomale Transformation | |
| JPH0773498B2 (ja) | 植物感染性キャップ化ｒｎａ分子 | |
| KR20150085846A (ko) | Tal-매개 전이 DNA 삽입방법 | |
| KR20010112952A (ko) | 바이러스 유전자 발현의 조절 | |
| WO1985004899A1 (en) | Methods and vectors for transformation of plant cells | |
| Thomas et al. | A mutation of cauliflower mosaic virus gene I interferes with virus movement but not virus replication | |
| CA2095109C (en) | Process for production of exogenous gene or its product in plant cells | |
| AU3618300A (en) | Multiple component rna vector system for expression of foreign sequences | |
| EP0938574B1 (en) | Method for inducing viral resistance into a plant | |
| US6093554A (en) | Genetics manipulations with recombinant DNA virus comprising sequences derived from RNA virus | |
| Radian-Sade et al. | Transgenic Nicotiana benthamiana and grapevine plants transformed with grapevine virus A (GVA) sequences | |
| Gupta et al. | Agrobacterium-mediated co-inoculation of okra plants with cloned okra enation leaf curl virus DNA and bhendi yellow vein mosaic beta-satellite DNA furthers Koch’s postulates for enation leaf curl disease | |
| HUT58794A (en) | Process for producing rns of endonuclease- and antisense activity | |
| NL8902452A (nl) | Genetische manipulaties met recombinant dna, dat rna-virus-specifieke sequenties omvat. | |
| Ravin et al. | Complete sequencing of potato virus X new strain genome and construction of viral vector for production of target proteins in plants | |
| US10308946B2 (en) | Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter | |
| WO1999061597A9 (en) | Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter | |
| US5959181A (en) | Method of preparation of transgenic plants resistant to viral infections and so obtained plants | |
| KR102280018B1 (ko) | 십자화과 작물에서 유용 유전자의 기능 분석을 위한 RaMV 유래의 재조합 VIGS 벡터 및 이의 용도 | |
| US5428144A (en) | Maize dwarf mosaic virus cDNA | |
| Arif et al. | FUROVIRUS IS ASSOCIATED WITH ACQUISITION | |
| Ravelonandro et al. | Transgenic tobacco plants that contain the plum pox virus (PPV) coat protein gene. | |
| Klöti | Genetic transformation of rice (Oryza sativa L.) to confer resistance to rice tungro bacilliform virus (RTBV) | |
| Wang | Isolation of phloem specific gene promoters for use in genetic engineering of insect resistance in rice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BV | The patent application has lapsed |